Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GLD vs MRNA✓SelectedUSD · MRNAGLD vs MRNA performance historyLatest closeAs of+0.16%11/13
Stock and ETF performance explorer

GLD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-7.2%
MRNA return
+755.5%
Excess return
-762.7%
Maximum drawdown
-28.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.2%-3.4%+3.6%+0.3%
7D-4.6%-12.1%+7.5%-4.2%
30D-5.5%-1.3%-4.2%-5.5%
3M-10.9%+250.9%-261.8%-16.6%
6M-17.4%+343.0%-360.5%-25.4%
YTD-10.3%+657.4%-667.8%-20.6%
1Y-7.2%+794.9%-802.1%-18.3%
All-7.2%+755.5%-762.7%-18.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling